Granted Patent
Utility
US 6,685,917
· Confirmation No. 1345
TREATMENT OF MUCOSITIS
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2011-09-06 | EBCC.AD |
Notice of Change of Address Place in File Wrapper Due to Electronic Business Center(EBC) Customer Number Update | 1 | View | |
| 2003-10-27 | IFEE |
Issue Fee Payment (PTO-85B) | 1 | View | |
| 2001-11-21 | TRNA |
Transmittal of New Application | 4 | View | |
| 2001-11-21 | SPEC |
Specification | 27 | View | |
| 2001-11-21 | CLM |
Claims | 13 | View | |
| 2001-11-21 | ABST |
Abstract | 1 | View | |
| 2001-11-21 | DRW |
Drawings-only black and white line drawings | 1 | View |
Inventors
Gary J. Rosenthal
Louisville, CO
Jeffrey B. Etter
Boulder, CO
Timothy C. Rodell
Aspen, CO
Wren H. Schauer
Boulder, CO
Adrian Samaniego
Louisville, CO
Attorneys & Agents of Record
Classification
USPC
424/49
Prosecution
- Examiner
- ROSE, SHEP K
- Art Unit
- 1614
- Customer No.
- 13586
- Docket No.
- 42830-00241
- Confirmation No.
- 1345
Publication
- Pub. No.
- US20020119104A1
- Pub. Date
- 2002-08-29
Patent Term Adjustment
-382days
Parent
is a Continuation in-part of
→
App. 09/721,516
Filed 2000-11-22
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 11/540,357
Filed 2006-09-29
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 10/728,277
Filed 2003-12-04
· Abandoned -- After Examiner's Answer or Board of Appeals Decision
Child
is a Continuation of
→
App. 11/525,983
Filed 2006-09-22
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 11/525,752
Filed 2006-09-22
· Abandoned -- Failure to Respond to an Office Action
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH HOLDINGS, LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.),
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-26
SECURITY INTEREST
Recorded 2017-06-08
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2002-02-27
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,685,917
- App. No.
- 09/993,383
- Filed
- 2001-11-21
- Granted
- 2004-02-03
- Pub. No.
- US20020119104A1
- Examiner
- ROSE, SHEP K
- Art Unit
- 1614
- PTA
- -382 days
External Links